OSIR
Osiris Therapeutics, Inc. Common Stock
OSIR
OSIR
Delisted
OSIR was delisted on the 16th of April, 2019.
67 hedge funds and large institutions have $133M invested in Osiris Therapeutics, Inc. Common Stock in 2014 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 22 increasing their positions, 24 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
74% less call options, than puts
Call options by funds: $1.22M | Put options by funds: $4.68M
Holders
67
Holding in Top 10
–
Calls
$1.22M
Puts
$4.68M
Top Buyers
| 1 | +$2.33M | |
| 2 | +$679K | |
| 3 | +$608K | |
| 4 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$408K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$265K |
Top Sellers
| 1 | -$2.63M | |
| 2 | -$1.33M | |
| 3 | -$962K | |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$656K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$332K |